Back
Biomarin Pharmaceutical Stock Predictions
Sponsored
BMRN
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
62
BMRN
Biomarin Pharmaceutical
Last Price:
$66.64
Seasonality Move:
5.39%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Biomarin Pharmaceutical Stock Forecast
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.8% based on the past 25 years of stock performance.
-
Biomarin Pharmaceutical has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%
-
Is Biomarin Pharmaceutical Stock Undervalued?The current Biomarin Pharmaceutical [BMRN] share price is $66.63. The Score for BMRN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.8% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical overpriced?
-
Biomarin Pharmaceutical has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.25
52-Week Low:
61.15
Prediction Charts
Market Cap:
12.7B
Price in USD:
66.63
Volume:
439K
Beta:
0.87
Technical Analysis
SMA50:
66.54
SMA100:
73.74
SMA200:
78.72
52-Wk Change:
-30.75%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?Yes, Biomarin Pharmaceutical is a publicly traded company.
-
What is the Biomarin Pharmaceutical stock quote today?The Biomarin Pharmaceutical stock price is 66.63 USD today.
-
How to buy Biomarin Pharmaceutical stock online?You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 66.05 | 66.16 | 66.92 | 65.38 |
Dec-6 | 66.89 | 66.74 | 67.20 | 65.79 |
Dec-9 | 66.33 | 66.81 | 67.87 | 66.33 |
Dec-10 | 67.00 | 66.43 | 67.07 | 66.13 |
Dec-11 | 66.42 | 65.97 | 67.05 | 65.49 |
Dec-12 | 65.45 | 66.26 | 66.68 | 65.35 |
Dec-13 | 66.08 | 66.01 | 66.27 | 64.89 |
Dec-16 | 66.50 | 65.54 | 67.17 | 65.42 |
Dec-17 | 64.89 | 67.19 | 67.85 | 64.80 |
Dec-18 | 67.19 | 64.66 | 67.58 | 64.60 |
Dec-19 | 64.63 | 65.00 | 65.62 | 63.93 |
Dec-20 | 64.90 | 65.69 | 66.27 | 64.07 |
Dec-23 | 65.07 | 66.27 | 66.46 | 64.65 |
Dec-24 | 65.96 | 66.63 | 67.09 | 65.25 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.